CLINICAL_TRIALS
trial_result
· 2020-04-06
Clinical Trial Update: Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia [Phase 2]
Summary
Phase 2 clinical trial update of fludarabine in treating chronic lymphocytic leukemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NCIC Clinical Trials Group | Conditions: Leukemia | Phase 2 | Status: COMPLETED